We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells. AhR-dependent reporter gene expression in transfected HepG2 cells was increased by pelargonidin in a concentration-dependent manner at 24h. Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme. Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR. Enzyme kinetic analyses using human liver microsomes revealed inhibition of CYP1A1 activity by delphinidin (IC50 78 μM) and pelargonidin (IC50 33 μM). Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity.

Department of Cell Biology and Genetics Faculty of Science Palacky University Slechtitelu 11 783 71 Olomouc Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc13023954

003      

CZ-PrNML

005      

20180214202129.0

007      

ta

008      

130703s2013 ne f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.toxlet.2013.01.020 $2 doi

035    __

$a (PubMed)23419638

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ne

100    1_

$a Kamenickova, Alzbeta $u Department of Cell Biology and Genetics, Faculty of Science, Palacky University, Slechtitelu 11, 783 71 Olomouc, Czech Republic.

245    10

$a Pelargonidin activates the AhR and induces CYP1A1 in primary human hepatocytes and human cancer cell lines HepG2 and LS174T / $c A. Kamenickova, E. Anzenbacherova, P. Pavek, AA. Soshilov, MS. Denison, P. Anzenbacher, Z. Dvorak,

520    9_

$a We examined the effects of anthocyanidins (cyanidin, delphinidin, malvidin, peonidin, petunidin, pelargonidin) on the aryl hydrocarbon receptor (AhR)-CYP1A1 signaling pathway in human hepatocytes, hepatic HepG2 and intestinal LS174T cancer cells. AhR-dependent reporter gene expression in transfected HepG2 cells was increased by pelargonidin in a concentration-dependent manner at 24h. Similarly, pelargonidin induced the expression of CYP1A1 mRNA up to 5-fold in HepG2 and LS174T cells relative to the induction by 5 nM 2,3,7,8-tetrachlorodibenzodioxin (TCDD), the most potent activator of AhR. CYP1A1 and CYP1A2 mRNAs were also increased by pelargonidin in three primary human hepatocytes cultures (approximately 5% of TCDD potency) and the increase in CYP1A1 protein in HepG2 and LS174T cells was comparable to the increase in catalytic activity of CYP1A1 enzyme. Ligand binding analysis demonstrated that pelargonidin was a weak ligand of AhR. Enzyme kinetic analyses using human liver microsomes revealed inhibition of CYP1A1 activity by delphinidin (IC50 78 μM) and pelargonidin (IC50 33 μM). Overall, although most anthocyanidins had no effects on AhR-CYP1A1 signaling, pelargonidin can bind to and activate the AhR and AhR-dependent gene expression, and pelargonidin and delphinidin inhibit the CYP1A1 catalytic activity.

650    _2

$a anthokyaniny $x farmakologie $7 D000872

650    _2

$a transkripční faktory bHLH $x účinky léků $x metabolismus $7 D051792

650    _2

$a cytochrom P-450 CYP1A1 $x biosyntéza $7 D019363

650    _2

$a vztah mezi dávkou a účinkem léčiva $7 D004305

650    _2

$a enzymová indukce $7 D004790

650    _2

$a buňky Hep G2 $7 D056945

650    _2

$a hepatocyty $x účinky léků $x enzymologie $7 D022781

650    _2

$a lidé $7 D006801

650    _2

$a střevní nádory $x enzymologie $7 D007414

650    _2

$a kinetika $7 D007700

650    _2

$a ligandy $7 D008024

650    _2

$a nádory jater $x enzymologie $7 D008113

650    _2

$a jaterní mikrozomy $x enzymologie $7 D008862

650    _2

$a primární buněčná kultura $7 D061251

650    _2

$a promotorové oblasti (genetika) $x účinky léků $7 D011401

650    _2

$a messenger RNA $x biosyntéza $7 D012333

650    _2

$a receptory aromatických uhlovodíků $x účinky léků $x metabolismus $7 D018336

650    _2

$a signální transdukce $x účinky léků $7 D015398

650    _2

$a polychlorované dibenzodioxiny $x farmakologie $7 D000072317

650    _2

$a aktivace transkripce $x účinky léků $7 D015533

650    _2

$a transfekce $7 D014162

655    _2

$a časopisecké články $7 D016428

655    _2

$a Research Support, N.I.H., Extramural $7 D052061

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Anzenbacherová, Eva $u - $7 stk2008428613 $4

700    1_

$a Pavek, Petr $u -

700    1_

$a Soshilov, Anatoly A $u -

700    1_

$a Denison, Michael S $u -

700    1_

$a Anzenbacher, Pavel $u - $7 xx0034447 $4

700    1_

$a Dvorak, Zdenek $u -

773    0_

$w MED00004537 $t Toxicology letters $x 1879-3169 $g Roč. 218, č. 3 (2013), s. 253-9

856    41

$u https://pubmed.ncbi.nlm.nih.gov/23419638 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20130703 $b ABA008

991    __

$a 20130709094732 $b ABA008

999    __

$a ok $b bmc $g 987634 $s 822334

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2013 $b 218 $c 3 $d 253-9 $i 1879-3169 $m Toxicology letters $n Toxicol Lett $x MED00004537

LZP    __

$a Pubmed-20130703